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To track the immunological level against 2009 H1N1 virus in
Beijing, China over time, we conducted a serological surveillance of
2009 H1N1 inﬂuenza in Beijing. Three serological surveys were
conducted: period 1 (December 31, 2009 to January 8, 2010),
period 2 (January 20, 2010 to January 28, 2010), and period 3
(March 9, 2010 to March 20, 2010). Subjects were selected from
patients visiting four tertiary hospitals (two children’s hospitals
and two adult hospitals), which are open to the general population,
and from members of the public donating blood at the Beijing
Blood Donation Center. Any patient requiring a blood test at the
outpatient blood collection rooms in these four hospitals were
screened for eligibility, and those visiting either the infection or
respiratory departments were excluded. A blood sample was
collected to detect antibodies against 2009 H1N1 inﬂuenza by
hemagglutination–inhibition (HI) assay; a titer 1:40 was
regarded as seropositivity.1,2
From January 2010 through March 2010, the seroprevalence of
2009 H1N1 inﬂuenza increased across age groups, genders, and
sources. Subjects aged 6–17 years recorded the highest seropre-Table 1
Results of serological surveillance of 2009 H1N1 inﬂuenza in Beijing, Chinaa
Period
Dec 3
Seroprevalence by age group, years
0–5b 9/41 (
6–17c 16/48
18–55c 23/16
56c 2/79 (
Totalc 50/32
Age-weighted seroprevalenced 14.4%
Seroprevalence by genderc
Male 22/16
Female 28/16
Seroprevalence by sourcec
Hospitale 39/24
Blood donation centerf 11/80
2009 H1N1 inﬂuenza vaccine uptake rateg 28/32
Seroprevalence in persons not receiving 2009 H1N1 inﬂuenza vaccinationc 41/30
Note. Data are proportion (%) of subjects, unless otherwise indicated.
a The serological surveillance of 2009 H1N1 inﬂuenza in Beijing began after the peak o
epidemic peak of 2009 H1N1 inﬂuenza in Beijing occurred in early November 2009 andw
in Beijing began on October 20, 2009 and lasted until the epidemic was over.
b p>0.05 for increasing seroprevalence by period (Chi-square test for trend).
c p<0.05 for increasing seroprevalence by period (Chi-square test for trend).
d Weighted by proportions of various age groups in the population of Beijing.
e Two children’s hospitals and two adult hospitals participated in this survey. Subjects
from adult hospitals.
f In China, persons aged 18–55 years are permitted to donate blood. Therefore, only
g p>0.05 for vaccine uptake rate by period (Chi-square test for trend).
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subjects aged56 years. In period 3, the seroprevalence in subjects
aged 6–17 years reached 54.7% and that in those aged 56 years
reached 22.0%; after weighting by proportions in the various age
groups in the population of Beijing,3 the age-weighted seropreva-
lence in the general population in Beijing reached 29.7%. The
uptake rates of 2009 H1N1 inﬂuenza vaccine were similar in the
three serological surveys. The seroprevalence in unvaccinated
persons increased signiﬁcantly during this surveillance (Table 1).
The epidemic peak of 2009 H1N1 inﬂuenza in Beijing occurred
in early November 2009 and waned to the baseline level in early
March 2010.4 The pandemic vaccination campaign in Beijing began
on October 20, 2009 and lasted until the epidemic was over. As of
mid-March 2010, the seroprevalence of 2009 H1N1 inﬂuenza in
the population of Beijing had reached 29%. Although the uptake
rate of the 2009H1N1 inﬂuenza vaccine did not increase during the
surveillance period, the seroprevalence increased signiﬁcantly.
Therefore, the increase in seroprevalence in Beijing was attributed
to natural infection during this period.
The advantage of serological surveillance conducted in hospi-
tals and blood donation centers is that it is more convenient and1 Period 2 Period 3
1, 2009–Jan 8, 2010 Jan 20,2010–Jan 28, 2010 Mar 9, 2010–Mar 20, 2010
22.0) 30/112 (26.8) 26/85 (30.6)
(33.3) 51/119 (42.9) 41/75 (54.7)
1 (14.3) 28/187 (15.0) 53/190 (27.9)
2.5) 6/52 (11.5) 11/50 (22.0)
9 (15.2) 115/470 (24.5) 131/400 (32.8)
17.7% 29.7%
8 (13.1) 60/255 (23.5) 70/215 (32.6)
1 (17.4) 55/215 (25.6) 61/185 (33.0)
9 (15.7) 96/394 (24.4) 96/320 (30.0)
(13.8) 19/76 (25.0) 35/80 (43.8)
9 (8.5) 41/470 (8.7) 34/400 (8.5)
1 (13.6) 85/429 (19.8) 103/366 (28.1)
f the pandemic and the start of the pandemic vaccination campaign in Beijing. The
aned to the baseline level in early March 2010. The pandemic vaccination campaign
aged <18 years were recruited from children’s hospitals and those aged 18 years
subjects aged 18–55 years could be recruited at blood donation centers.
ses. Published by Elsevier Ltd. All rights reserved.
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precise information for health departments to make policy
decisions.
Acknowledgements
Supported by grants from the National High Technology
Research and Development Program of China (863 Program;
2008AA02Z416), Beijing Natural Science Foundation (7082047),
Program of China during the 11th Five-Year Plan Period
(2009ZX10004-315), and Program of Research on Strategy of
Prevention and Control for 2009H1N1 inﬂuenza in Beijing from the
Beijing Science and Technology Commission.
Ethical approval: This serological surveillance was approved by
the Institutional Review Board and Human Research Ethics
Committee of the Beijing Center for Disease Prevention and
Control.
Conﬂict of interest: No conﬂict of interest to declare.
References
[1] Olsen CW, Brammer L, Easterday BC, Arden N, Belay E, Baker I, et al. Serologic
evidence of H1 swine inﬂuenza virus infection in swine farm residents and
employees. Emerg Infect Dis 2002;8:814–9.[2] Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, et al. Serologic survey of
pandemic (H1N1) 2009 virus, Guangxi Province. China Emerg Infect Dis
2009;15:1849–50.
[3] Guo D, Yin Y. Data assembly of the sampling survey on 1% population in Beijing
in 2005. Beijing: China Statistics Press; 2007, 97–9.
[4] Yang P, Qian H, Peng X, Liang H, Huang F, Wang Q. Alternative epidemic of
different types of inﬂuenza in 2009-2010 inﬂuenza season, China. Clin Infect Dis
2010;51:631–2.
Peng Yang
Weixian Shi
Lili Tian
Shuang Li
Li Zhang
Fang Huang
Quanyi Wang*
Beijing Center for Disease Prevention and Control (CDC), Capital
Medical University School of Public Health and FamilyMedicine, No.16
He Pingli Middle Street, Dongcheng District, Beijing 100013, China
*Corresponding author. Tel.: +86 10 6440 7108;
fax: +86 10 6440 7113
E-mail address: bjcdcxm@126.com
(Q. Wang)
Corresponding Editor: William Cameron, Ottawa, Canada
